Investment
Features
FeesSafety
Academy
More
Pluang+

Schwab Fundamental US Large Company ETF rated Buy for value focus and diversification over S&P 500

Analyst Insights
07 Oct 2026
Seeking Alpha
View Source
Bullish
Schwab Fundamental US Large Company ETF rated Buy for value focus and diversification over S&P 500

The Schwab Fundamental US Large Company ETF (FNDX) receives a Buy rating due to its value-driven, fundamentally weighted approach that offers lower price-to-earnings and price-to-cash flow ratios compared to the S&P 500. It emphasizes quality and shareholder value while providing broad sector diversification, reduced tech sector concentration, and less dependence on top holdings. This makes FNDX a strong option for core portfolio holdings or for rotating assets, especially when technology stocks appear overvalued or market risk appetite changes.

The Schwab Fundamental US Large Company ETF (FNDX) is discussed here, with Pluang market data providing context. For readers following US stocks on Pluang as of Oct 07, 2026 22:02 WIB: out of 150 priced US stocks, 38 rose and 111 fell. Notable movers include BlackBerry Limited (BB) at USD 9.24 with a 1-day change of -3.55% and a typical hold time of 50 days, Baker Hughes Co (BKR) at USD 55.11 down 3.54% with a typical hold time of 75 days, and Halliburton Company (HAL) at USD 31.58 down 3.48% with a typical hold time of 88 days. Pluang order activity shows BB with 40% sell and 60% buy, while BKR and HAL show 0% sell and 100% buy.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
2 hours ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
2 hours ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
3 hours ago
Jito Labs launches JTX, a self-custodial trading platform for pro traders on Solana.

Jito Labs launches JTX, a self-custodial trading platform for pro traders on Solana.

Jito Labs has introduced JTX, a new self-custodial trading platform on the Solana blockchain. The platform supports spot trading of tokens, memecoins, tokenized equities, and ETFs, providing professional-grade execution tools. This launch aims to emp...

Protocol Fundamentals
Bullish
4 hours ago
Evernorth's $1B XRP fund launch on NASDAQ delayed to Oct 12 due to administrative error, not market issues.

Evernorth's $1B XRP fund launch on NASDAQ delayed to Oct 12 due to administrative error, not market issues.

Evernorth's $1 billion XRP-only fund, initially set to debut on NASDAQ on October 8, 2026, has been postponed to October 12 due to an administrative delay. This delay does not affect the recent merger approval by Armada II shareholders or the fund's ...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App